+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 3.842 HKD | -0.226 | -5.556% | 296.72M | 1.18B | 4.083 (-5.900%) HKD as at 2024/11/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 3.570 HKD | +0.170 | +5.000% | 283.26M | 980.85M | 3.393 (+5.207%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 3.584 HKD | -0.144 | -3.863% | 140.08M | 511.64M | 3.724 (-3.759%) HKD as at 2024/11/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.020 HKD | +0.150 | +3.876% | 125.06M | 492.89M | 3.879 (+3.630%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.694 HKD | -0.274 | -6.905% | 13.08M | 48.63M | 3.988 (-7.370%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 2.216 HKD | -0.100 | -4.318% | 9.83M | 21.94M | 2.304 (-3.815%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 12.160 HKD | +0.300 | +2.530% | 1.35M | 16.27M | 11.926 (+1.964%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 4.092 HKD | -0.388 | -8.661% | 2.45M | 10.39M | 4.472 (-8.495%) HKD as at 2024/11/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.195 HKD | -0.070 | -1.330% | 1.87M | 9.69M | 5.188 (+0.139%) HKD as at 2024/11/21 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.938 HKD | +0.100 | +2.067% | 1.74M | 8.50M | 4.850 (+1.808%) HKD as at 2024/11/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 3.208 HKD | +0.142 | +4.631% | 2.62M | 8.31M | 3.085 (+3.977%) HKD as at 2024/11/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.787 HKD | -0.010 | -1.255% | 5.33M | 4.19M | 0.785 (+0.216%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 25.060 HKD | +0.340 | +1.375% | 128.50K | 3.22M | 25.100 (-0.159%) HKD as at 2024/11/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 66.100 HKD | -1.100 | -1.637% | 17.93K | 1.19M | 67.272 (-1.743%) HKD as at 2024/11/21 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | S&P Bitcoin Futures Index | 4.886 HKD | -0.114 | -2.280% | 135.90K | 667.87K | 4.934 (-0.975%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 32.840 HKD | +0.460 | +1.421% | 9.00K | 295.68K | 32.920 (-0.243%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Nikkei Stock Average Index | 72.340 HKD | +1.380 | +1.945% | 780.00 | 56.47K | 71.197 (+1.606%) HKD as at 2024/11/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | FTSE Taiwan RIC Capped Index | 13.710 HKD | +0.550 | +4.179% | 3.30K | 45.24K | 1.691 (+4.182%) USD as at 2024/11/21 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | FTSE Taiwan RIC Capped Index | 4.490 HKD | -0.088 | -1.922% | 5.40K | 24.29K | 0.587 (-1.711%) USD as at 2024/11/21 | | |